JHS Svendgaard Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
JHS Svendgaard Laboratories Ltd · Financial Result · 04 Nov 2026, 5:35 pm
JHS Svendgaard Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 2,183 (-2.0% YoY | -28.1% QoQ) ■ EBITDA: 51.2 (-43.7% YoY | -75.3% QoQ) ■ EBITDA Margin (%): 2.3 (-173 bps YoY | -448 bps QoQ) ■ PAT: 50.6 (Loss to Profit YoY | -53.6% QoQ) ■ EPS (INR): 0.06 (Loss to Profit YoY | -50.0% QoQ)
Original exchange filing (PDF)
More announcements from JHS Svendgaard Laboratories Ltd
- Un-Audited Financial Results for the Quarter and Half Year Ended 30th September, 2026 · 04 Nov 2026
- Statement of Deviation and Variation for the quarter ended 30 September, 2026. · 03 Nov 2026
- Board of Directors approved the appointment of Mr. Pardeep Kumar Bhardwaj as an Additional Non-Executive Independent Director of the Company. · 03 Nov 2026
- Board of Directors in their meeting dated 02 November, 2026 approved the unaudited Standalone and Consolidated financials for quarter and half year ended 30 September, 2026. · 03 Nov 2026
- JHS Svendgaard Laboratories Limited has submitted to the Exchange, Un-audited-financial results for the period ended September 30, 2026. · 02 Nov 2026
- Board of Directors approved the unaudited standalone and consolidated financials for quarter and half year ended 30 September, 2026. · 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 02 Nov 2026
- JHS SVENDGAARD LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 02 Nov 2026
